VERTEX PHARMACEUTICALS INC (VRTX)

US92532F1003 - Common Stock

452.08  +1.71 (+0.38%)

Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to VRTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 523.05. This target is 15.7% above the current price.
VRTX was analyzed by 40 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about VRTX.
In the previous month the buy percentage consensus was at a similar level.
VRTX was analyzed by 40 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 452.08328.25540.60523.05630.00 - -27.39% 19.58% 15.70% 39.36%
Up and Down Grades
Date Firm Action Rating
2024-11-14 Citigroup Initiate Buy
2024-11-06 Canaccord Genuity Maintains Sell -> Sell
2024-11-05 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-11-05 ScotiaBank Maintains Sector Perform -> Sector Perform
2024-11-05 UBS Maintains Buy -> Buy
2024-11-05 RBC Capital Maintains Sector Perform -> Sector Perform
2024-11-05 JP Morgan Maintains Overweight -> Overweight
2024-11-05 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-10-30 Oppenheimer Maintains Outperform -> Outperform
2024-10-21 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-17 UBS Maintains Buy -> Buy
2024-10-16 ScotiaBank Initiate Sector Perform
2024-10-14 B of A Securities Maintains Buy -> Buy
2024-10-10 Raymond James Reiterate Market Perform
2024-10-09 RBC Capital Maintains Sector Perform -> Sector Perform
2024-10-08 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-10-04 RBC Capital Maintains Sector Perform -> Sector Perform
2024-10-01 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-09-19 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-08-05 Oppenheimer Maintains Outperform -> Outperform
2024-08-05 Barclays Downgrade Overweight -> Equal-Weight
2024-08-05 Truist Securities Reiterate Buy -> Buy
2024-08-05 JP Morgan Maintains Overweight -> Overweight
2024-08-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-02 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-02 Guggenheim Maintains Buy -> Buy
2024-08-02 Piper Sandler Maintains Overweight -> Overweight
2024-07-31 Canaccord Genuity Maintains Sell -> Sell
2024-07-26 Needham Reiterate Hold
2024-07-23 TD Cowen Maintains Buy -> Buy